Sayar Hamid - Indiana Univ Sch Med, Indiana Univ Simon Canc Ctr

基本信息

浏览量：27

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 67 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract CT060: Phase 1 Study of Azacitidine in Combination with Evorpacept for Higher-Risk Myelodysplastic Syndrome (MDS)

Guillermo Garcia-Manero,Bart L. Scott,Ashwin Kishtagari,Srinivasa R. Sanikommu,Aref Al-Kali,Je-Hwan Lee, Juan M. Bergua Burgues,Maria Diez-Campelo,Harry P. Erba,Carmen Garcia-Hernandez,Guillermo Sanz Santillana,Casey O'Connell, Jun-Ho Jang,Dong-Yeop Shin,Hamid Sayar,Mayank Rao,Richard S. Schwartz, Grace An, Feng Jin,Alison J. Forgie,Athanasios C. Tsiatis,Jessica K. Altman

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

P62SQSTM1 Affects Interacting Substrates MDM2, MDMX and Casein Kinase 1alpha to Yield Protection of Beta-Catenin along with P53 Silencing for Refractory AML

Justin Layer,Sravanti Rangaraju,Santhosh Pasupuleti,Larry D. Cripe,Hamid Sayar,Katie J. Sargent,Jill Weisenbach, Huda S. Salman,G. David Roodman,Linsey Mayo,Reuben Kapur,Utpal P. Dave,H. Scott Boswell

Blood（2022）

引用0浏览0引用

P498: clinical and biological markers associated with long-term survival for patients with acute myeloid leukemia (aml) in remission after chemotherapy in the quazar aml-001 trial of oral azacitidine

A. H. Wei,H. Döhner,H. Sayar,F. Ravandi,P. Montesinos,H. Dombret,D. Selleslag,K. Porkka,J.-H. Jang,B. Skikne,C. Beach,T. Prebet,G. Zhang,A. Risueño, M. Ugidos Guerrero, W. L. See, D. Menezes,G. J. Roboz

HemaSphere (2022): 397-398

引用0浏览0引用

AML-457 Oral Azacitidine (Oral-AZA) in Patients With Acute Myeloid Leukemia (AML) in First Remission after Intensive Chemotherapy (IC): Long-Term Overall Survival (OS) Results from the Phase 3 QUAZAR AML-001 Trial

Farhad Ravandi,Andrew H Wei,Hartmut Döhner,Hamid Sayar,Pau Montesinos,Hervé Dombret,Dominik Selleslag,Kimmo Porkka,Jun Ho Jang,Barry Skikne,C L Beach,Yu Olivia Tian,Gail J Roboz

Clinical Lymphoma Myeloma and Leukemia (2022)

引用0浏览0WOS引用

Oral Azacitidine (Oral-AZA) in Patients With Acute Myeloid Leukemia (AML) in First Remission after Intensive Chemotherapy (IC): Long-Term Overall Survival (OS) Results from the Phase 3 QUAZAR AML-001 Trial

Farhad Ravandi,Andrew H. Wei,Hartmut Doehner,Hamid Sayar,Pau Montesinos,Herve Dombret,Dominik Selleslag,Kimmo Porkka,Jun Ho Jang,Barry Skikne,C. L. Beach,Yu (Olivia) Tian,Gail J. Roboz

Blood（2022）

引用5浏览0WOS引用

Current Results on Overall Survival with oral Azacitidine Therapy in Patients with acute Myeloid Leukemia in first Remission after intensive Chemotherapy in the Phase 3 QUAZAR Study

M. Pfeilstoecker,A. H. Wei,H. Doehner,H. Sayar,F. Ravandi,P. Montesinos,H. Dombret,D. Selleslag,K. Porkka,J. H. Jang,B. Skikne,C. Beach, Y. O. Tian,G. J. Roboz

ONCOLOGY RESEARCH AND TREATMENTno. SUPPL 2 (2022): 66-67

引用0浏览0引用

Does Race Play a Role in Complications and Outcomes of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms

Andrew M. Peseski,Antoine N. Saliba,Sandra K. Althouse,Hamid Sayar

Hematology/oncology and stem cell therapy（2021）

引用3浏览0WOS引用

Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial

Ravandi Farhad, New York Presbyterian Hospital,Monash University,Döhner Hartmut,Pocock Christopher,Selleslag Dominik,Montesinos Pau,Sayar Hamid,Musso Maurizio, Figuera-Alvarez Angela,Safah Hana,Tse William,Sohn Sang Kyun,Hiwase Devendra,Chevassut Timothy,Pierdomenico Francesca,La Torre Ignazia, Bristol Myers Squibb,Bailey Rochelle,Zhong Jianhua,Beach C. L., Université de Paris

Journal of Hematology & Oncology（2021）

引用11浏览0WOS引用

Gastrointestinal events and management strategies for patients with acute myeloid leukemia (AML) in first remission receiving oral azacitidine (Oral-AZA) in the randomized, placebo-controlled, phase 3 QUAZAR AML-001 maintenance trial

M. Pfeilstocker,F. Ravandi,C. Pocock,D. Selleslag,P. Montesinos,H. Sayar,M. Musso,A. Figuera,H. Safah,W. Tse,S. K. Sohn,D. Hiwase,T. Chevassut,F. Pierdomenico,I La Torre,B. Skikne,C. L. Beach,H. Dombret

ONCOLOGY RESEARCH AND TREATMENT（2021）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn